Brain Cancer

Cerebral Glioblastoma

Male, 35 years

Patient Internal 777141807

ICD-10 code

C71.8 Malignant Neoplasm of Overlapping Sites of Brain

Diagnosis (Incl. Metastases/Stage) and Year

January 2021
Glioblastoma, WHO Grade IV, ATRX (-), MGMT (-), IDH (+).

Previous Treatment

Surgery, Radiation Therapy, Chemotherapy (Temozolomide).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of Glioblastomas being around 14 months from diagnosis.

Treatment Provided

Autologous DCV (11 doses) and CIK (16 doses) over a period of 17 months.

Patient Survival/Condition and Year
Date of Review: 17/02/2024

The patient has survived for 31 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy and Radiation Therapy, has extended patient survival by an estimate of around 18 months.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok